Unanswered Questions.

Open Access

Unanswered Questions.

Session: A Changing Paradigm: Defining the Future Role of SGLT-2 Inhibitors

Topic: Chronic Heart Failure

Speaker: Professor A. Stewart Coats (Sydney, AU) Professor B. Bozkurt (Houston, US) Professor C. Lam (Singapore, SG)

Organised by Radcliffe Medical Education - Supported by an unrestricted educational grant from the Boehringer Ingelheim & Lilly Alliance

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speakers

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)

111 presentations

21 followers

Professor Biykem Bozkurt

Baylor College of Medicine, Houston (United States of America)

24 presentations

5 followers

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

147 presentations

50 followers

5 more presentations in this session

SGLT-2 Inhibitors in Heart Failure: Where are we now and where are we heading?

Speaker: Professor A. Stewart Coats (Sydney, AU)

Access

Summary of how the Tx paradigm for HF has changed.

Speaker: Professor B. Bozkurt (Houston, US)

Access

Best practice of SGLT-2 inhibitors in HFrEF: What constitutes best practice today?

Speaker: Professor C. Lam (Singapore, SG)

Access

Implementation in Practice: What are the Practical Considerations?

Speaker: Professor A. Stewart Coats (Sydney, AU) Professor C. Lam (Singapore, SG) Professor B. Bozkurt (Houston, US)

Access

Q&A.

Speaker: Professor A. Stewart Coats (Sydney, AU) Professor B. Bozkurt (Houston, US) Professor C. Lam (Singapore, SG)

Access

Access the full session

A Changing Paradigm: Defining the Future Role of SGLT-2 Inhibitors

Speakers: Professor A. Stewart Coats, Professor B. Bozkurt, Professor C. Lam, Professor A. Stewart Coats, Professor B. Bozkurt...

Access

Video

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Unanswered Questions.

About the speakers

Professor Andrew Stewart Coats

Professor Biykem Bozkurt

Professor Carolyn Sp Lam

5 more presentations in this session

SGLT-2 Inhibitors in Heart Failure: Where are we now and where are we heading?

Summary of how the Tx paradigm for HF has changed.

Best practice of SGLT-2 inhibitors in HFrEF: What constitutes best practice today?

Implementation in Practice: What are the Practical Considerations?

Q&A.

Access the full session

A Changing Paradigm: Defining the Future Role of SGLT-2 Inhibitors

About the event

ESC Congress 2021 - The Digital Experience

ESC 365 is supported by